These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31415830)

  • 1. Poly(ornithine)-based self-assembling drug for recovery of hyperammonemia and damage in acute liver injury.
    Vong LB; Ibayashi Y; Lee Y; Ngo DN; Nishikawa Y; Nagasaki Y
    J Control Release; 2019 Sep; 310():74-81. PubMed ID: 31415830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
    Vogels BA; Karlsen OT; Mass MA; Boveé WM; Chamuleau RA
    J Hepatol; 1997 Jan; 26(1):174-82. PubMed ID: 9148009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.
    Seiler N
    Curr Drug Targets; 2000 Sep; 1(2):119-53. PubMed ID: 11465067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.
    Saheki T; Moriyama M; Kuroda E; Funahashi A; Yasuda I; Setogawa Y; Gao Q; Ushikai M; Furuie S; Yamamura KI; Takano K; Nakamura Y; Eto K; Kadowaki T; Sinasac DS; Furukawa T; Horiuchi M; Tai YH
    Sci Rep; 2019 Mar; 9(1):4179. PubMed ID: 30862943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.
    Kudo S; Nagasaki Y
    J Control Release; 2015 Nov; 217():256-62. PubMed ID: 26386436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of thioacetamide-induced liver damage on the brain uptake indices of ornithine, arginine and lysine: modulation by treatment with ornithine aspartate.
    Albrecht J; Hilgier W; Januszewski S; Quack G
    Metab Brain Dis; 1996 Sep; 11(3):229-37. PubMed ID: 8869943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.
    Zanatta Â; Viegas CM; Hickmann FH; de Oliveira Monteiro W; Sitta A; de Moura Coelho D; Vargas CR; Leipnitz G; Wajner M
    Cell Mol Neurobiol; 2015 Aug; 35(6):797-806. PubMed ID: 25772141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice.
    Shimizu D; Ishitsuka Y; Miyata K; Tomishima Y; Kondo Y; Irikura M; Iwawaki T; Oike Y; Irie T
    Pharmacol Res; 2014 Sep; 87():26-41. PubMed ID: 24951965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
    Stravitz RT; Gottfried M; Durkalski V; Fontana RJ; Hanje AJ; Koch D; Hameed B; Ganger D; Subramanian RM; Bukofzer S; Ravis WR; Clasen K; Sherker A; Little L; Lee WM;
    Hepatology; 2018 Mar; 67(3):1003-1013. PubMed ID: 29080224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
    Nicaise C; Prozzi D; Viaene E; Moreno C; Gustot T; Quertinmont E; Demetter P; Suain V; Goffin P; Devière J; Hols P
    Hepatology; 2008 Oct; 48(4):1184-92. PubMed ID: 18697211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully biodegradable and cationic poly(amino oxalate) particles for the treatment of acetaminophen-induced acute liver failure.
    Kim H; Kim Y; Guk K; Yoo D; Lim H; Kang G; Lee D
    Int J Pharm; 2012 Sep; 434(1-2):243-50. PubMed ID: 22664461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.
    Uzi D; Barda L; Scaiewicz V; Mills M; Mueller T; Gonzalez-Rodriguez A; Valverde AM; Iwawaki T; Nahmias Y; Xavier R; Chung RT; Tirosh B; Shibolet O
    J Hepatol; 2013 Sep; 59(3):495-503. PubMed ID: 23665281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
    Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
    Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
    Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
    Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency].
    Sikorska H; Cianciara J; Wiercińska-Drapało A
    Pol Merkur Lekarski; 2010 Jun; 28(168):490-5. PubMed ID: 20642112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication.
    Seiler N; Grauffel C; Daune G; Gerhart F
    Life Sci; 1989; 45(11):1009-19. PubMed ID: 2507845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.